Review
Version 1
Preserved in Portico This version is not peer-reviewed
Tailoring Rheumatoid Arthritis Treatment through a Gender Lens
Version 1
: Received: 15 November 2023 / Approved: 15 November 2023 / Online: 16 November 2023 (03:06:31 CET)
A peer-reviewed article of this Preprint also exists.
Carmona, L.; Aurrecoechea, E.; García de Yébenes, M.J. Tailoring Rheumatoid Arthritis Treatment through a Sex and Gender Lens. J. Clin. Med. 2024, 13, 55. Carmona, L.; Aurrecoechea, E.; García de Yébenes, M.J. Tailoring Rheumatoid Arthritis Treatment through a Sex and Gender Lens. J. Clin. Med. 2024, 13, 55.
Abstract
Rheumatoid arthritis (RA) occurs more frequently in women than in men, and the studies that have addressed clinical and prognostic differences between sexes are scarce and have contradictory results and methodological problems.
The present work aims to evaluate sex and gender-related differences in the clinical expression and prognosis of RA as well as the impact on psychosocial variables, coping behavior, and healthcare use and access.
By identifying between-sex differences and gender-related outcomes in RA, it may be possible to design tailored therapeutic strategies that consider the differences and unmet needs. Being sex, together with age, the most relevant biomarker and health determinant, a so-called personalized medicine approach to RA must include clear guidance on what to do in case of differences.
Keywords
rheumatoid arthritis; gender; sex; susceptibility; treatment effect
Subject
Medicine and Pharmacology, Other
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment